Skip to content

comparison of efficacy of pistacia atlantial oleoresin with that of placebo in treatment of patients with functional dyspepsia

comparison of efficacy of pistacia atlantial oleoresin with that of placebo in treatment of patients with functional dyspepsia

Status
Recruiting
Phases
Early Phase 1
Study type
Interventional
Source
IRCT
Registry ID
IRCT20210124050126N1
Enrollment
70
Registered
2021-02-16
Start date
2021-02-19
Completion date
Unknown
Last updated
2021-02-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Functional dyspepsia.

Interventions

Intervention 1: In this study, two groups of 35 persons will participate, which is a control group, treated with 9 grams of mastic gum (0.9gr / day) per day in 3 divided doses with famotidine 40 mg ta

Sponsors

Bagheiat-allah University of Medical Sciences
Lead Sponsor
Bagheiat-allah University of Medical Sciences
Collaborator

Eligibility

Sex/Gender
All
Age
15 Years to 65 Years

Inclusion criteria

Inclusion criteria: Age 15 to 65 years, Patients with ROME4 criteria including recurrent abdominal pain that recurs on average at least once a week for at least three months abdominal pain associated with bowel movements and the frequency and appearance of bowel movements any abdominal discomfort, any Abdominal discomfort species

Exclusion criteria

Exclusion criteria: IBS, PUD, GERD CHF, DM, ATHMA, COPD and, , , , Psychological diseases history of alcohol and opium addiction ,gastrointestinal surgery need for continuous use of cardiological drugs antihypertensive antipsychotic sedatives antibiotics corticosteroids

Design outcomes

Primary

MeasureTime frame
Flatulence, premature satiety, loss of appetite. Timepoint: 2 and 4 weeks after starting to use L Pistacia atlantica gum. Method of measurement: Hong Kong Questionnaire.

Secondary

MeasureTime frame
Quality of Life. Timepoint: 2 and 4 weeks after the onset of gum. Method of measurement: Quality of Life Questionnaire sf-36.

Countries

Iran (Islamic Republic of)

Contacts

Public Contactmorteza jodi chelansofla

Bagheiat-allah University of Medical Sciences

saidejudi766@gmail.com+98 41 3740 5295

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026